Literature DB >> 28162203

[Guidelines on life-style modification for Chinese breast cancer survivors].

.   

Abstract

Existing evidences proved that healthy life style after diagnosis contributes to better overall survival and quality of life for breast cancer survivors. The healthy life style includes maintaining healthy weight, regular physical activity and healthy diet. In order to address the concerns of the breast cancer survivors in their disease free and long-term survival period, and provide instruction to the clinical and public health professionals, breast cancer survivors and their families, Breast Health Group(BEST: Breast Education Screening Diagnosis and Treatment Group), the Branch of Women Health of Chinese Preventive Medicine Association convened experts to systematically evaluate the existing evidences and the characteristics of Chinese breast cancer survivors, developed guidelines on the life-style modification for breast cancer survivors. The suggestion and recommendation in the guideline aim to help the breast cancer survivors to take healthy diet, keep regular physical activity and maintain healthy weight, for improving overall health, prognosis, and quality of life over their long term survivorship.

Entities:  

Keywords:  Breast neoplasms; Guidebooks; Life style

Mesh:

Year:  2017        PMID: 28162203     DOI: 10.3760/cma.j.issn.0529-5815.2017.02.001

Source DB:  PubMed          Journal:  Zhonghua Wai Ke Za Zhi        ISSN: 0529-5815


  2 in total

Review 1.  Development of health behaviour questionnaire for breast cancer women in Mainland China.

Authors:  Hui Xu; Guichun Jiang; Xiujie Zhang; Daqiu Wang; Lei Xu; Aiping Wang
Journal:  Nurs Open       Date:  2020-12-23

2.  A Short-Term Effect of Wearable Technology-Based Lifestyle Intervention on Body Composition in Stage I-III Postoperative Breast Cancer Survivors.

Authors:  Changming Zhou; Miao Mo; Zezhou Wang; Jie Shen; Jiajian Chen; Lichen Tang; Jiajia Qiu; Yiqun Ling; Huiping Ding; Qin Jiang; Hui Wang; Zhimin Shao; Ying Zheng
Journal:  Front Oncol       Date:  2020-10-20       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.